Skip to main content

Table 1 Details of patients with stroke enrolled in Robotic Group and Control Group

From: Evidence of neuroplasticity with robotic hand exoskeleton for post-stroke rehabilitation: a randomized controlled trial

Measures

Pre-therapy measures robotic group (n = 12) Mean ± SD

Pre-therapy measures control group (n = 11) Mean ± SD

p-value

Age (years)

41.1 ± 12.8

42.7 ± 9.3

0.75

Chronicity (months)

13.8 ± 9.1

10.3 ± 5.0

0.47

MAS

1.75 ± 0.2

1.86 ± 0.5

0.46

AROM (degrees)

15.0 ± 9.7

13.6 ± 7.7

0.34

BI

74.1 ± 12.4

69.5 ± 12.9

0.41

BS

3.67 ± 0.7

3.72 ± 1

0.9

FMU/L

36 ± 7.7

37.45 ± 9.1

0.98

FMW/H

9.7 ± 2.7

11.45 ± 2.9

0.27

FMS/E

26.2 ± 5.6

26 ± 7.07

0.78

Lesion Volume (cm3)

25.3 ± 45.48

15.9 ± 23.6

0.97

  1. MAS (max 4) Modified Ashworth Scale, AROM (max 70) Active Range of Motion
  2. BI (max 100) Barthel Index, BS (max 7) Brunstorm Stage
  3. FMU/L (max 66) Fugl-Meyer Upper Limb Scale, FMW/H (max 24) Fugl-Meyer Wrist Hand
  4. FMS/E (max 42) Fugl-Meyer Shoulder Elbow